Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Chan-Ping You"'
Publikováno v:
Biomolecules, Vol 12, Iss 1, p 72 (2022)
Biomarkers can be used for diagnosis, prognosis, and prediction in targeted therapy. The estrogen receptor α (ERα) and human epidermal growth factor receptor 2 (HER2) are standard biomarkers used in breast cancer for guiding disease treatment. The
Externí odkaz:
https://doaj.org/article/4491e14a9c0c4dba88ebeb266f5190ac
Autor:
Ho Tsoi, Nicholas Nok-Ching Fung, Ellen P. S. Man, Man-Hong Leung, Chan-Ping You, Wing-Lok Chan, Sum-Yin Chan, Ui-Soon Khoo
Publikováno v:
Cancers; Volume 15; Issue 8; Pages: 2271
About 70% of breast cancer patients are oestrogen receptor-positive (ER +ve). Adjuvant endocrine therapy using tamoxifen (TAM) is an effective approach for preventing local recurrence and metastasis. However, around half of the patients will eventual
Autor:
Ho Tsoi, Wai-Chung Tsang, Ellen P. S. Man, Man-Hong Leung, Chan-Ping You, Sum-Yin Chan, Wing-Lok Chan, Ui-Soon Khoo
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 20; Pages: 12290
Breast cancer is a heterogeneous disease. Tamoxifen is frequently used to treat ER-positive breast cancer. Our team has identified a novel splice variant of NCOR2, BQ323636.1 (BQ), that mediates tamoxifen resistance. However, the upstream factors tha
Publikováno v:
Cancers. 14(5)
Breast cancer is a heterogeneous disease. Around 70% of breast cancers are estrogen receptor-positive (ER+ve), with tamoxifen being most commonly used as an adjuvant treatment to prevent recurrence and metastasis. However, half of the patients will e
Publikováno v:
Cancer Research. 78:1108-1108
Cancer metastasis is a major cause of mortality, accounting for approximately 90% of cancer related deaths. Emerging evidences suggest that tumour microenvironment plays an indispensable role in cancer metastasis. Recruitment of innate and adaptive i
Autor:
Ali, Belal M.1,2, El-Abhar, Hanan S.3, Abdallah, Dalaal M.1, Mohamed, Ghada4,5, Sharaky, Marwa6, Shouman, Samia A.6, Kamel, Marwa6 Hanan.elabhar@fue.edu.eg
Publikováno v:
Indonesian Journal of Pharmacy / Majalah Farmasi Indonesia. 2023, Vol. 34 Issue 4, p617-629. 13p.
Autor:
Tsoi, Ho1 (AUTHOR) tsoiho@hku.hk, Fung, Nicholas Nok-Ching1 (AUTHOR) nickf821@connect.hku.hk, Man, Ellen P. S.1 (AUTHOR) ellenman@hku.hk, Leung, Man-Hong1 (AUTHOR) george09@connect.hku.hk, You, Chan-Ping1 (AUTHOR) u3006037@connect.hku.hk, Chan, Wing-Lok2 (AUTHOR) winglok@hku.hk, Chan, Sum-Yin3 (AUTHOR) ann_chan81@hotmail.com, Khoo, Ui-Soon1 (AUTHOR) uskhoo@pathology.hku.hk
Publikováno v:
Cancers. Apr2023, Vol. 15 Issue 8, p2271. 20p.
Autor:
You, Chan-Ping1 (AUTHOR), Tsoi, Ho1 (AUTHOR), Man, Ellen P. S.1 (AUTHOR), Leung, Man-Hong1 (AUTHOR), Khoo, Ui-Soon1 (AUTHOR) uskhoo@pathology.hku.hk
Publikováno v:
International Journal of Molecular Sciences. Dec2022, Vol. 23 Issue 23, p15342. 14p.
Autor:
Tsoi, Ho1 (AUTHOR), Tsang, Wai-Chung1 (AUTHOR), Man, Ellen P. S.1 (AUTHOR), Leung, Man-Hong1 (AUTHOR), You, Chan-Ping1 (AUTHOR), Chan, Sum-Yin2 (AUTHOR), Chan, Wing-Lok3 (AUTHOR), Khoo, Ui-Soon1 (AUTHOR) uskhoo@pathology.hku.hk
Publikováno v:
International Journal of Molecular Sciences. Oct2022, Vol. 23 Issue 20, p12290-N.PAG. 18p.
Autor:
Tsoi, Ho, Lok, Johann, Man, Ellen PS, Cheng, Cheuk‐Nam, Leung, Man‐Hong, You, Chan‐Ping, Chan, Sum‐Yin, Chan, Wing‐Lok, Khoo, Ui‐Soon
Publikováno v:
Journal of Pathology; Oct2023, Vol. 261 Issue 2, p156-168, 13p